Gedeon Richter receives “The Most Innovative Product” award from gynaecologists for Ryeqo® and is ranked second in the Pharma Trend Ranking 2022

The specialist group of gynaecologists awards Gedeon Richter 2022 for its preparation Ryeqo® with the award “The most innovative product”. In the interdisciplinary ranking “Best Pharmaceutical Companies in Germany”, Gedeon Richter moves up 5 places in the category “Large individual, medium-sized and international companies” in 2022 and takes 2nd place. InfectoPharm was ranked first and … [Read more…]

Janssen-Cilag honoured for innovation and sustainability with the award “The Golden Tablet” of the urologists and is number 1 in the Pharma Trend Ranking 2022

Janssen-Cilag places first in the “Best Pharmaceutical Companies” 2022 ranking in Germany in the category “Research-based global leaders by sales”. Janssen-Cilag also wins the award for innovation and sustainability “The Golden Tablet” 2022 of the urologists. The runner-up places here went to Bayer and Apogepha. Janssen-Cilag’s latest innovation in the field of urology is Erleada® … [Read more…]

BioNTech wins the “Golden Tablet” of general practitioners, receives the award “The Most Innovative Product” twice for Comirnaty® and places 6th in the Pharma Trend Ranking 2022

BioNTech wins the “Golden Tablet of General Practitioners, Practitioners and Internists (APIs) in Pharma Trend 2022, repeating its success from the previous year. The “APIs” as well as the paediatricians’ specialist group also give the company the award “The Most Innovative Product” for its COVID vaccine Comirnaty®. BioNTech thus places 6th in the inter-specialist “Best … [Read more…]

Astellas ranks 10th in Pharma Trend Ranking 2022

In the multispecialty ranking “Best Pharmaceutical Companies Germany” 2022, Astellas comes in 10th place in the category “research-based, world-leading pharmaceutical companies by sales”. The first places in the category go to Janssen-Cilag, Novartis and Bayer Vital/Jenapharm. Astellas has long been one of the market leaders in Germany in the therapeutic fields of urology and transplant … [Read more…]

Dr. Kade ranks 3rd in the Pharma Trend Ranking 2020

Dr. Kade is ranked 3rd in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. The latest new launch and candidate for the award “The Most Innovative Product” 2021 in the OTC category is the wash lotion KadeFemin®, which contains moisturising hyaluronic acid as well as a … [Read more…]

Bionorica ranks second in the Pharma Trend Ranking 2020

Bionorica is ranked second in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In addition, Bionorica wins the pharmacists’ award “The Golden Tablet” in the OTC category.

Dr. Falk Pharma ranks 4th in the Pharma Trend Ranking 2020

Dr. Falk Pharma is ranked 4th in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In Pharma Trend, Dr. Falk Pharma was recognised for innovation for the last time in 2018 with Jorveza®, which was awarded “The Most Innovative Product” by gastroenterologists in the OD category.

Grünenthal ranks 10th in Pharma Trend Ranking 2020

Grünenthal is ranked 10th in the multispecialty ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. In Pharma Trend, Grünenthal was awarded for innovation for the first time in 2020 with Palexia®, which received the award “The Most Innovative Product” in the Rx category from pain therapists.

MOVENTIG® named “Most Innovative Product” 2020

Constipation, stomach pains, and nausea affect patients with opioid-induced constipation (OIC) to such an extent that they can be forced to discontinue treatment. Conventional laxatives are often insufficient. The new PAMORA drug class can help target the adverse intestinal effects of opioids – without negatively affecting central pain inhibition. Naloxegol (MOVENTIG®) is the first of … [Read more…]

Jorveza®: Innovation through ingenious galenics

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, which can be effectively treated with topical steroids. Yet until recently, no mode of administration had been approved and optimised specifically for EoE. This gap has now been closed by the new budesonide orodispersible tablet (with effervescent quality) Jorveza®, which gastroenterologists considered the … [Read more…]